Blood Type Identification Reagent Polyclonal
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3822130000 | 10.0% | CN | US | 官方文档 |
| 3822190080 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
🩸 Blood Type Identification Reagent (Polyclonal)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional-Level Entry Strategy
📌 I. Product Definition and Classification: Do You Really Understand "Blood Grouping Reagents"?
Blood type identification reagents, specifically polyclonal antibodies, are critical diagnostic tools used to determine the ABO and Rh blood groups of patients. In international trade, these are categorized as prepared diagnostic reagents.
Key Distinction in Classification:
- Heading 3006: Covers specific medical diagnostic kits and reagents (e.g., pregnancy tests, ovulation tests).
- Heading 3822: Covers ALL other diagnostic or laboratory reagents, whether on a backing, prepared, or in kit form, excluding those of Heading 3006.
⚠️ Critical Classification Point:
Since blood group reagents (polyclonal or monoclonal) are not explicitly listed under Heading 3006, they fall under Heading 3822.
- If on a backing or in a specific kit format for blood grouping → 3822.13.00.00
- If otherwise prepared (e.g., liquid vials, loose kits, or other forms) → 3822.19.00.80
📦 II. HS Code Classification Details (2026 Latest Tariff Authority Comparison)
| HS Code | Product Description | Application Scenario | Tax Rate (Total) |
|---|---|---|---|
3822.13.00.00 |
Diagnostic or laboratory reagents on a backing, prepared reagents, whether or not on a backing, whether or not put up in the form of kits: For blood-grouping | Polyclonal anti-A, anti-B, anti-D sera; Blood grouping cards/chips; Pre-packaged blood typing kits | 0.0% |
3822.19.00.80 |
Diagnostic or laboratory reagents on a backing, prepared reagents, whether or not on a backing, whether or not put up in the form of kits: Other Other: Other | Liquid polyclonal reagents (not on backing/kits); Other specialized lab reagents; Reagents not specifically for blood grouping | 0.0% |
🔍 Key Reminder:
- The core distinction lies in form and specific use.
- If the product is explicitly for blood grouping (e.g., anti-A/B/D reagents), even if not on a backing, it often falls under 3822.13 if interpreted as "prepared reagents for blood-grouping".
- If the product is a general laboratory reagent (polyclonal antibody for research, not specifically marketed as a blood-grouping kit), it may fall under 3822.19.
- Both HS Codes have a 0.0% tariff rate, minimizing cost impact, but correct classification is essential for compliance and regulatory clearance (FDA/CLIA in the US, CE in EU).
💰 III. 2026 Latest Tariff Rate Details (Including Surcharges, Policy Add-ons)
✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Time: 2025年11月10日起 (Following subsequent imports)
🎯 1. 3822.13.00.00 —— Reagents for Blood-Grouping (Polyclonal/Anti-A/Anti-B/Anti-D)
| Item | Content |
|---|---|
| Base Tariff Rate | 0% (ad valorem) |
| USITC Additional Tariff | 0% (No specific footnote applies to 3822.13 in most current lists for general diagnostic reagents) |
| IEEPA Additional Tariff | 0% (Diagnostic reagents often exempt or not included in high-tariff lists for this subheading) |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0% = $0 |
| De Minimis Eligibility | ✅ Yes (If under $800, subject to standard de minimis rules; however, FDA regulations still apply) |
| Legal Basis Path | HTSUS:3822.13.00.00 → USTR Note: No additional duty |
📌 Explanation:
- Diagnostic reagents for blood grouping are classified under 3822.13.
- Crucially, the tariff is 0.0%, meaning no customs duty is levied at the border.
- However, regulatory clearance (FDA, CLIA, CAP) is mandatory, not tariff payment.
🎯 2. 3822.19.00.80 —— Other Prepared Diagnostic Reagents (e.g., Liquid Polyclonal Antibodies)
| Item | Content |
|---|---|
| Base Tariff Rate | 0% (ad valorem) |
| USITC Additional Tariff | 0% |
| IEEPA Additional Tariff | 0% |
| Total Tax Rate | 0.0% |
| Tax Calculation | CIF Value × 0% = $0 |
| De Minimis Eligibility | ✅ Yes (Under $800) |
| Legal Basis Path | HTSUS:3822.19.00.80 → USTR Note: No additional duty |
📌 Note:
- Even if not specifically packaged as a "blood-grouping kit," if it is a prepared diagnostic reagent, it falls under 3822.19.
- Still 0.0% tariff, but regulatory scrutiny may be higher if not clearly labeled for diagnostic use.
🛠️ IV. Customs Clearance Practical Advice (Practical Pitfall Avoidance Guide)
✅ 1. Required Documentation Checklist (None Missing)
| Document | Must Provide | Explanation |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Must clearly state: "Polyclonal Antibody," "Anti-A," "Anti-B," "Anti-D," "For In Vitro Diagnostic Use Only" |
| ✅ Letter of Authorization (if OEM) | ✔️ | If manufactured by third party, provide authorization letter |
| ✅ FDA Registration Number | ✔️ | Importer must have FDA facility registration; product must be listed |
| ✅ CE Marking (for EU) | ✔️ | If exporting to Europe, CE certification is mandatory |
| ✅ Commercial Invoice | ✔️ | Clearly describe as "Blood Grouping Reagents, Polyclonal, For Diagnostic Use" |
| ✅ Certificate of Analysis (COA) | ✔️ | Shows titer, specificity, and purity |
| ✅ Storage Conditions | ✔️ | Often requires 2-8°C; specify cold chain logistics |
✅ 2. Declaration Tips (Key Mantra)
🔥 "Diagnostic Labeling, Reagent Nature, Blood Group Specific, 0% Tariff!"
| Scenario | Correct Declaration | Incorrect Practice |
|---|---|---|
| Polyclonal Anti-A/B/D in vials | 3822.13.00.00 (if for blood grouping) |
Declare as "Chemical Reagent" → 3822.00 (Higher scrutiny) |
| Blood typing card/chip | 3822.13.00.00 |
Declare as "Medical Device" → 9018 (Different tariff/regulation) |
| Generic Polyclonal Antibody (Research Use) | 3822.19.00.80 |
Declare as "For Blood Grouping" → Misclassification penalty |
| Reagent for Research Only (Not Diagnostic) | 3822.19.00.80 |
Declare as "Diagnostic" → FDA refusal |
✅ 3. Special Case Handling
| Scenario | Handling Advice |
|---|---|
| OEM Custom Reagents | Provide client order + design drawings to prove "For Blood Grouping" |
| Reagents with "Research Use Only" Label | Must declare as 3822.19.00.80 and NOT for diagnostic use; FDA cannot clear for diagnostic use |
| Cold Chain Shipment | Specify "Refrigerated" on invoice; ensure temperature log is provided |
| Human Origin Material | May require additional FDA 7544 declaration or explanation of animal-derived components |
🌍 V. Global Market Customs Clearance Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff | Certification Requirements | Remarks |
|---|---|---|---|---|
| 🇺🇸 USA | 3822.13.00.00 |
0% | FDA Registration + CLIA/CAP | 0% tariff, but strict FDA control |
| 🇨🇳 China | 3822.13.00.00 |
0% | NMPA Registration | 0% tariff |
| 🇪🇺 EU | 3822.13.00.00 |
0% | CE IVDD/IVDR + GDPR | 0% tariff under EU-Chili/other FTAs if applicable |
| 🇦🇺 Australia | 3822.13.00.00 |
5% | TGA Registration | Slight tariff, but still low |
| 🇯🇵 Japan | 3822.13.00.00 |
0% | PMDA Approval | 0% tariff |
📌 Conclusion:
- Tariff is 0.0% in most major markets for blood grouping reagents;
- Regulatory compliance (FDA/CE) is the main barrier, not tariffs;
- USA: No tariff, but high regulatory scrutiny;
- EU: CE Marking is mandatory under IVDR;
- Australia: 5% tariff, but still competitive.
📌 VI. Common Errors & Pitfall Guide (Blood and Tears Lessons)
❌ Error 1: Declaring "Blood Reagent" as "Chemical Reagent" (29xx)
👉 Consequence: Wrong classification, potential penalty, and FDA refusal.
❌ Error 2: Failing to specify "For Blood Grouping" in description
👉 Consequence: Customs may classify under 3822.19 (Other), which is still 0%, but triggers different regulatory reviews.
❌ Error 3: Not providing FDA Registration Number
👉 Consequence: Shipment detained at port, returned or destroyed.
❌ Error 4: Labeling as "For Research Use Only" but claiming Diagnostic Use
👉 Consequence: FDA Class 3 violation, heavy fines, and shipment seizure.
✅ Correct Practice:
"Blood Grouping Reagent, Polyclonal Anti-A, Anti-B, Anti-D, For In Vitro Diagnostic Use, Not for Research Only, FDA Registered, Store at 2-8°C"
🎯 VII. Conclusion: Professional Declaration, Save Time, Reduce Cost, Increase Efficiency!
🎯 Remember the Mantra:
🔹 "Diagnostic Reagent, Blood Grouping, 0% Tariff, FDA First!"
🔹 "HS Code is 3822, Tariff is Zero, but Regulation is Key!"
📌 Tips:
- If your reagents are polyclonal and for blood grouping, ensure the label clearly states "For Blood Grouping" to qualify for 3822.13.00.00.
- Always verify FDA status before shipment;
- Cold chain logistics must be documented.
📣 Immediate Action:
📞 Contact a professional customs broker + Provide FDA Registration Number + Apply for Advance Ruling (if uncertain)
🚀 Let your blood grouping reagents, pass customs smoothly, efficient export, profit maximized!
✨ Professional Customs Clearance, Starts with Accurate Classification!
💼 Every penny of your cost, deserves to be precisely calculated!
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。